Bone marrow transplant cost in Thailand

Bone marrow transplant cost in Thailand by transplant type, donor pathway, and inpatient risk

A hematopoietic transplant estimate must describe the disease, treatment intent, autologous or allogeneic pathway, donor or collection work, conditioning medicines, stem-cell collection and infusion, isolation, transfusion, infection support, graft-versus-host prevention, intensive care, and follow-up. A low admission figure may exclude the medicines and complications that determine much of the real budget. For an international patient, the Thai transplant center must also review donor eligibility, visas, caregiver support, accommodation after discharge, and access to urgent care after returning home.

How much does a bone marrow transplant cost in Thailand?

An autologous hematopoietic transplant in Thailand may be planned at THB 1,650,000 to 3,300,000, about USD 50,000 to 100,000, depending on disease, collection, conditioning, admission, and complications. An allogeneic transplant from a matched related, unrelated, or alternative donor may range from THB 2,640,000 to 5,940,000, about USD 80,000 to 180,000. Cord or alternative donor work, prolonged infection, graft-versus-host disease, ICU, organ injury, or relapse treatment can take the cumulative budget above THB 6,600,000, about USD 200,000+. These are planning bands and not a promise of cure or survival.

USD examples use approximately THB 33 per USD, near the Bank of Thailand reference checked in July 2026. Transplant quotations may be split between THB admission, imported medicines, donor testing, cell collection, blood products, and complication care. Ask which currency controls each stage and how the hospital handles an extended stay.

Review cost scenarios Upload reports

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Patient Name

Country

Phone Number

Describe The Current Medical Problem

Reviewed 2026-07-19

Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team

Billing context: THB and USD

Transplant type changes the whole budget

Autologous and allogeneic transplant differ in donor work, immune complications, medicines, infection exposure, and length of follow-up.

Donor availability is not a purchase

A transplant center must verify compatibility, consent, medical eligibility, registry rules, and lawful cell collection. No coordinator can promise an organ or donor.

The first admission is not the entire journey

Readmission, infection, graft-versus-host disease, transfusion, nutrition, rehabilitation, and relapse care can add months of treatment.

Caregiver support is clinical

A caregiver may need to monitor temperature, medicines, hydration, hygiene, food safety, and urgent symptoms after discharge.

Home continuity must exist

A patient should know where blood tests, transfusions, antimicrobial treatment, immunosuppression, and urgent transplant review will occur.

Cost at a glance

Planning scenarios for bone marrow and hematopoietic stem-cell transplant in Thailand

The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.

Estimated bone marrow and hematopoietic stem-cell transplant cost scenarios in Thailand
Scenario	THB	USD	Patient and treatment context	Planning scope
Autologous transplant	THB 1,650,000 - 3,300,000	USD 50,000 - 100,000	A selected patient whose own stem cells are collected, stored, and returned after high-dose conditioning for an appropriate disease.	Should include mobilization, collection, storage, conditioning, infusion, isolation, transfusion, infection support, and early review.
Allogeneic related-donor pathway	THB 2,640,000 - 5,280,000	USD 80,000 - 160,000	A patient needing donor cells from a compatible family donor with conditioning, graft-versus-host prevention, and prolonged follow-up.	Separate donor work, HLA testing, collection, conditioning, infusion, immunosuppression, infection, transfusion, and caregiver stay.
Alternative donor or complex course	THB 4,950,000 - 9,900,000+	USD 150,000 - 300,000+	A patient needing unrelated, haploidentical, or cord source, intensive conditioning, repeat collection, ICU, graft complications, or relapse care.	Requires disease-specific review, donor availability, cell-source terms, infection and organ-risk planning, and contingency billing.

Usually included

Check the clinical package scope

Transplant eligibility

Hematology review, disease status, marrow and imaging, infection screen, organ function, performance status, fertility, and consent.

The treating disease team must confirm indication.

Collection and infusion

Mobilization, apheresis or donor collection, cell processing and storage, conditioning, infusion, and identity checks.

Autologous and donor scope must be separate.

Inpatient transplant care

Isolation, central line, transfusion, antibiotics or antivirals, monitoring, nutrition, nursing, and transplant rounds.

Ask for daily room, ICU, and blood rates.

Discharge handover

Medicines, infection prevention, graft monitoring, clinic schedule, caregiver teaching, records, and emergency contact.

Long-term follow-up is not optional.

Confirm separately

Charges that may sit outside the range

Disease treatment before or after

Induction, salvage chemotherapy, radiation, targeted therapy, maintenance, relapse therapy, or another transplant.

Ask whether the quote covers only transplant admission.

Donor and cell-source work

HLA testing, registry search, donor travel, unrelated or haploidentical collection, cord processing, storage, and transport.

Cell source must be legally and clinically verified.

Complication care

Sepsis, viral or fungal infection, graft-versus-host disease, organ injury, bleeding, ICU, dialysis, ventilation, or readmission.

Obtain contingency rates.

Home and caregiver budget

Accommodation, food, translation, flights, medicines, blood tests, transfusion, local clinician, caregiver, and delayed return.

Plan a buffer beyond the package.

Candidate context

Who may be considered and what else may be discussed

Hematopoietic stem-cell transplant can be considered for selected blood cancers, marrow failure, immune disorders, metabolic disease, or other conditions when the expected benefit outweighs conditioning, infection, organ, infertility, graft, and relapse risks. The team should assess disease response, measurable disease, prior therapy, marrow, heart, lung, kidney, liver, infection, frailty, nutrition, fertility, mental health, caregiver, and donor or cell-source feasibility. An international patient should receive a written plan from the transplant center rather than a generic “BMT package.”

Information that shapes suitability

Transplant-responsive disease

The hematologist should explain the treatment goal, disease status, relapse risk, and why transplant is being recommended now.

Organ and infection readiness

Heart, lung, kidney, liver, dental, viral, bacterial, fungal, and vaccination assessment influences conditioning and timing.

Cell source and compatibility

Autologous collection or donor HLA and medical eligibility must be confirmed before the patient commits to travel.

Caregiver and home access

The patient needs an adult caregiver, local accommodation, temperature monitoring, blood testing, and urgent transplant access after discharge.

Informed fertility and quality-of-life choices

Fertility preservation, goals, infection precautions, immune recovery, work, school, and long-term risks should be discussed.

Alternatives or sequencing questions

Disease-directed therapy

Chemotherapy, immunotherapy, targeted medicine, radiation, transfusion, or supportive care may be considered before or instead of transplant.

Reduced-intensity pathway

Selected older or medically vulnerable patients may be assessed for lower-intensity conditioning, with different relapse and graft risks.

Clinical trial or second opinion

Disease biology, measurable residual disease, donor options, and new therapies can justify a specialist review before a major commitment.

Local transplant program

When donor logistics, infection risk, or home follow-up are not workable in Thailand, a capable local or nearer center may be safer.

Procedure variations

Why the named procedure does not have one price

Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.

Autologous transplant

The patient’s own collected stem cells are returned after high-dose treatment.

Immune graft complications differ from donor transplant.

Related-donor allogeneic transplant

Cells come from a compatible family donor after donor and recipient evaluation.

HLA, donor health, consent, and graft-versus-host prevention matter.

Unrelated or haploidentical donor

A registry or partly matched donor may be used when a full family match is unavailable.

Availability and rules must be confirmed by the center.

Cord or alternative source

A banked cord source or another specialized cell source may be considered for selected patients.

Cell dose, processing, transport, and timing alter cost.

City comparison

Cost and capability by city in Thailand

Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.

Estimated bone marrow and hematopoietic stem-cell transplant costs and planning context by city in Thailand
City	Local range	USD range	Capability context	Stay planning
Bangkok	THB 1,980,000 - 9,900,000+	USD 60,000 - 300,000+	Broadest concentration of transplant, hematology, infection, ICU, laboratory, and international departments.	Verify cell-processing laboratory, donor pathway, isolation, ICU, and post-discharge clinic.
Chiang Mai	THB 1,650,000 - 7,920,000+	USD 50,000 - 240,000+	Selected university and tertiary hematology programs may provide transplant care.	Ask about donor sources, cell processing, ICU, and long-term infection support.
Phuket	THB 1,815,000 - 7,260,000+	USD 55,000 - 220,000+	International hospitals offer coordination, while complex transplant capability must be verified case by case.	A tourism setting is not a substitute for protected transplant infrastructure.
Pattaya and Chon Buri	THB 1,650,000 - 6,600,000+	USD 50,000 - 200,000+	Eastern hospitals provide hematology services with transplant depth varying by institution.	Confirm whether transplant is onsite or requires Bangkok referral.
Khon Kaen	THB 1,584,000 - 6,600,000+	USD 48,000 - 200,000+	Northeastern tertiary care may support selected transplant pathways.	Verify cell processing, isolation, donor work, and ICU.
Hat Yai and Songkhla	THB 1,584,000 - 6,600,000+	USD 48,000 - 200,000+	Southern regional hematology services may suit selected cases after center confirmation.	Plan caregiver and urgent infection access.
Nakhon Ratchasima	THB 1,485,000 - 5,940,000+	USD 45,000 - 180,000+	Regional specialist services with hospital-level variation.	Ask for a named transplant physician and cell-lab pathway.
Chiang Rai	THB 1,485,000 - 5,610,000+	USD 45,000 - 170,000+	Regional hematology assessment may be available; complex transplant may require referral.	A transfer plan should be documented before admission.
Udon Thani	THB 1,452,000 - 5,940,000+	USD 44,000 - 180,000+	Selected regional care can coordinate treatment and referral.	Verify isolation, blood supply, and infection management.
Rayong	THB 1,584,000 - 6,270,000+	USD 48,000 - 190,000+	Eastern Thailand access with center-specific transplant capability.	Do not infer transplant depth from general hospital size.

Estimate variables

What can change the final hospital cost

Transplant type

Autologous versus donor transplant changes collection, conditioning, immune medicines, infection, graft, and admission needs.

Do not compare unlike pathways.

Cell source and donor

Related, unrelated, haploidentical, cord, registry, HLA, processing, transport, and donor medical work affect cost and timing.

Availability must be verified.

Conditioning and disease status

Diagnosis, prior treatment, intensity, measurable disease, organ reserve, and relapse risk affect medicines and length of stay.

The hematologist should itemize pre-treatment.

Infection and graft complications

Antimicrobials, transfusion, graft-versus-host disease, ICU, dialysis, ventilation, and readmission can dominate the budget.

Ask for daily and event rates.

Caregiver and home continuity

Isolation housing, food, translation, flights, blood tests, medicines, caregiver, local hospital, and delayed return are real costs.

Keep a large contingency.

Medical cost breakdown

Before admission, in hospital, and after discharge

Diagnostics and preparation

Disease and marrow status

Marrow, pathology, molecular and cytogenetic studies, imaging, measurable residual disease, and treatment response.

The transplant indication needs current evidence.

Organ and infection screen

Heart, lung, kidney, liver, dental, viral, bacterial, fungal, vaccination, and endocrine or fertility review.

Old negative tests may need repeating.

Donor and compatibility

HLA typing, donor health, consent, registry or cell-bank coordination, and cell-source feasibility.

A donor cannot be assumed.

Admission and treatment

Conditioning and collection

Mobilization, apheresis, central line, cell processing or donor collection, storage, conditioning, and identity checks.

Autologous and donor invoices differ.

Transplant admission

Isolation, infusion, transfusion, antimicrobial prevention and treatment, nutrition, monitoring, and daily transplant rounds.

Ask room, ICU, and blood rates.

Discharge readiness

Engraftment, medicines, caregiver teaching, infection plan, blood tests, clinic schedule, and emergency route.

Discharge is not cure.

Recovery and follow-up

Engraftment period

Low blood counts, fever, mucositis, nutrition, transfusion, infection, pain, and fluid or organ monitoring.

Any fever needs immediate transplant-team advice.

Early outpatient care

Blood tests, antimicrobial medicines, central-line care, graft monitoring, immunosuppression, and readmission planning.

Stay near the hospital as advised.

Survivorship

Vaccination, immune recovery, fertility, endocrine, organ, bone, chronic graft disease, relapse, and rehabilitation follow-up.

Long-term care needs a home center.

Complete journey budget

Plan beyond the hospital invoice

Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.

Before travel

Disease review, donor confirmation, hospital acceptance, infection screening, visa, insurance, caregiver, and accommodation.

Do not fly before cell-source acceptance.

Protected stay

Hospital, isolation, caregiver, food, translation, local transport, blood tests, medicines, and extra nights.

Flexible lodging is essential.

Return planning

Safe blood counts, infection plan, home hematologist, medicines, transfusion, urgent access, and delayed flight.

The transplant center must approve travel.

Country access

Rules and practical requirements to verify

Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.

Verify the transplant center

Check hospital authorization, transplant physician, cell-processing laboratory, isolation, infection, ICU, blood bank, and international-patient pathway.

Confirm lawful donor and cell route

A center must verify HLA, donor consent and health, registry or bank rules, processing, transport, and identity controls. Donor cells are not a retail product.

Use Thai quality resources

Healthcare accreditation and Medical Hub sources offer facility context, but the transplant program must confirm its exact disease and donor capability.

Confirm THB billing

Ask about conditioning, donor work, collection, cell processing, storage, blood, isolation, ICU, medicines, and complication rates.

Use official visa guidance

Check Thailand e-Visa or embassy requirements and plan caregiver, medical documents, and a potentially prolonged stay.

Hospital selection

Compare capability before package price

Complete transplant program

Confirm hematologist, transplant physician, cell laboratory, infection, ICU, transfusion, pharmacy, nutrition, and psychosocial support.

A chemotherapy center is not always a transplant center.

Cell identity and governance

Ask about collection, labelling, cryostorage, chain of custody, thaw, infusion, and adverse-event reporting.

Identity controls are essential.

Infection and ICU depth

Verify isolation, antimicrobial support, ICU, dialysis, ventilation, blood products, and emergency surgery.

Complication capability matters.

Complete price

List conditioning, collection, cell processing, admission, isolation, blood, medicines, ICU, donor work, and overstay.

Compare the complete pathway.

Home transplant handover

Provide transplant summary, cell source, medicines, blood counts, vaccination, infection, graft, and relapse plan.

Home hematology must be arranged before travel.

Treating team

Specialists and support that may matter

Transplant hematologist

Confirms disease, transplant type, conditioning, donor or collection route, complications, and long-term plan.

Cell-processing and transfusion team

Manages collection, identity, processing, storage, thaw, infusion, blood products, and quality controls.

Infection and critical-care team

Prevents and treats infection, organ injury, sepsis, graft complications, ICU need, and readmission.

Caregiver and survivorship team

Teaches medicines, hygiene, food safety, temperature, follow-up, fertility, vaccination, rehabilitation, and home escalation.

Treatment timeline

From report review to return-home follow-up

Disease and donor review

Send pathology, marrow, molecular, imaging, prior treatment, organ, infection, HLA, and donor records.

Transplant acceptance

The Thai program confirms disease status, donor or cell source, conditioning, caregiver, isolation, THB budget, and travel timing.

Collection and conditioning

Stem cells are collected or prepared, stored when needed, and the patient receives the planned conditioning treatment.

Infusion and engraftment

Cells are infused with identity checks while the patient receives isolation, transfusion, infection, nutrition, and organ support.

Discharge and nearby care

After engraftment and clinical stability, the patient remains close for blood tests, medicines, graft monitoring, and urgent review.

Home survivorship

Continue hematology, vaccination, immune recovery, organ, graft, fertility, relapse, and rehabilitation care.

Risks and edge cases

Events that can change the plan, stay, or cost

Disease progression

A transplant may be delayed or reconsidered if disease response, marrow, infection, or organ status changes.

The plan must allow re-evaluation.

Severe infection

Neutropenia, line infection, fungal disease, viral reactivation, sepsis, and pneumonia can require ICU and prolonged admission.

Fever is an emergency.

Graft-versus-host disease

Allogeneic transplant can cause acute or chronic immune injury affecting skin, gut, liver, lungs, eyes, mouth, and other organs.

Long-term treatment may be needed.

Organ injury

Liver, kidney, lung, heart, neurological, mucosal, and nutritional complications can extend recovery.

Ask for event-based rates.

Donor or cell delay

HLA, donor health, registry timing, cell dose, transport, or legal documentation may change dates.

Do not book rigid flights.

Home-care gap

No caregiver, blood-test access, isolation housing, medicines, or emergency hematology can make discharge unsafe.

Arrange continuity before travel.

Destination comparison

Compare India, Turkey, and Thailand for this procedure

The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.

Procedure planning comparison across India, Turkey, and Thailand
Decision factor	India	Turkey	Thailand	How to use this
Transplant depth	Large hematology and transplant market with strong city-level variation.	Tertiary transplant centers and international programs vary by disease and donor pathway.	Bangkok is the broadest hub, with selected university and regional programs.	Verify cell laboratory, infection, ICU, and home handover.
Donor pathway	Donor and registry rules are nationally and center regulated.	Donor and cell-source eligibility must be confirmed at the exact center.	Thai Red Cross and transplant systems provide national coordination context; patient-specific eligibility remains with the center.	Never treat donor cells as a package add-on.
Cost scope	Conditioning, medicines, admission, and complications may be separated.	International quotes vary in medicines and donor work.	THB admission offers may exclude cell processing, donor, blood, or readmission.	Compare the full transplant episode and first year.
Travel	Strong South Asian and Gulf access.	Strong Europe, Gulf, and Central Asian access.	Strong Southeast and East Asian access.	Choose where caregiver and urgent follow-up are practical.

Decision guidance

When Thailand may fit and when to keep comparing

Thailand may fit when

A transplant center confirms disease, donor or cell route, lab, conditioning, isolation, complications, caregiver, and home hematology handover.

Keep comparing when

A coordinator promises a donor, quotes only the admission, minimizes infection, or cannot name the cell-processing and transplant team.

Delay travel when

Disease status, infection, organ reserve, cell source, caregiver, or home blood-test access is not settled.

Seek urgent care

Fever, breathlessness, bleeding, confusion, severe diarrhea, rash, reduced urine, line redness, or sudden weakness needs immediate transplant-team care.

Reports for review

Prepare a case file before requesting estimates

Prepare pathology, marrow, molecular and cytogenetic reports, imaging, treatment timeline, disease response, HLA and donor records, heart, lung, kidney, liver, infection, dental, fertility, medicines, allergies, vaccination, and caregiver information. Request a Thai proposal that separates autologous or allogeneic plan, conditioning, collection, cell processing, donor, isolation, blood, ICU, medicines, complications, THB validity, and home handover.

Upload medical reports

Disease file

Diagnosis

Send pathology, marrow, molecular, cytogenetic, flow, imaging, and measurable-disease results with dates.

Treatment history

List chemotherapy, radiation, targeted or immune therapy, response, complications, transfusion, and prior transplant.

Current status

Provide blood counts, symptoms, infection, performance, nutrition, and organ function.

Transplant goal

Ask the hematologist to explain intent, alternatives, relapse, fertility, and long-term expectations.

Donor and readiness

HLA and donor

Send typing, related donor details, registry or bank information, consent, and donor health when available.

Organ screen

Include heart, lung, kidney, liver, dental, viral, bacterial, fungal, and vaccination records.

Medicines

List current treatment, prophylaxis, steroids, anticoagulants, allergies, and supplements.

Caregiver and travel

Share caregiver, accommodation, passport, visa, language, insurance, and flexible travel.

Quote questions

Cell pathway

Ask for collection, donor, HLA, lab, processing, storage, thaw, transport, and identity controls.

Admission scope

Request conditioning, isolation, transfusion, medicines, infection, ICU, blood, readmission, and overstay.

Home handover

Confirm blood tests, medicines, infection, graft, vaccination, relapse, and emergency contact.

Consent and privacy

Read health data, donor information, samples, cancellation, refund, and complaint terms.

Common questions

Questions about cost, travel, and follow-up

What is the bone marrow transplant cost in Thailand?

Autologous pathways may be around THB 1,650,000 to 3,300,000, about USD 50,000 to 100,000, while allogeneic or complex care can exceed THB 5,280,000.

What is the difference between autologous and allogeneic transplant?

Autologous uses the patient’s own collected cells; allogeneic uses donor cells and adds compatibility, graft-versus-host, donor, and immune-management issues.

Can a foreign patient get a donor in Thailand?

The transplant center must confirm legal, medical, HLA, consent, registry, cell-source, and timing requirements. Donor access cannot be promised by a coordinator.

Does the package include chemotherapy?

Conditioning may be included, but disease treatment before transplant, relapse therapy, targeted medicines, donor work, and complications can be separate.

How long do I stay in Thailand?

The protected transplant admission can be prolonged, followed by nearby outpatient monitoring. The center must set the timing based on engraftment and stability.

What happens after discharge?

Blood tests, medicines, infection prevention, graft monitoring, transfusion, nutrition, and urgent review continue for weeks or months.

Is a transplant a guaranteed cure?

No. Outcome depends on disease, response, donor, infection, graft complications, organ reserve, relapse, and biology.

Can I travel alone?

Transplant patients commonly need a reliable caregiver and nearby accommodation. The center should assess practical support before travel.

What if I develop fever?

Fever after transplant is an emergency. Follow the center’s instructions and go to the nearest capable hospital immediately.

What records should I bring home?

Bring transplant summary, cell source, conditioning, medicines, blood results, infection and graft plan, vaccination advice, and hematology contacts.

Review and sources

How this guide was prepared

Ranges distinguish autologous transplant, related-donor allogeneic treatment, and alternative-donor or complex courses. The working conversion is approximately THB 33 per USD using the Bank of Thailand source checked in July 2026. The estimate expands conditioning and admission into donor or cell work, processing, isolation, transfusion, infection, graft complications, caregiver, and home follow-up. Thai transplant and quality sources inform provider checks; specialist guidance informs clinical questions. The center must provide the final disease-specific THB budget.

This page is educational and cannot establish transplant indication, donor access, cell-source eligibility, cure, survival, or Thai hospital licensing. A transplant hematology team must review disease, donor, organ, infection, caregiver, and home-care readiness. Fever, breathlessness, bleeding, confusion, severe diarrhea, rash, reduced urine, or line redness needs immediate transplant-team care.

Related planning